Profund Advisors’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-29,348
Closed -$212K 1176
2024
Q3
$212K Buy
29,348
+6,389
+28% +$58.5K 0.01% 1023
2024
Q2
$249K Sell
22,959
-37,624
-62% -$482K 0.01% 840
2024
Q1
$1.14M Buy
60,583
+10,870
+22% +$251K 0.04% 327
2023
Q4
$1.08M Sell
49,713
-19,042
-28% -$377K 0.05% 310
2023
Q3
$1.41M Buy
68,755
+43,076
+168% +$1.24M 0.08% 204
2023
Q2
$1.21M Sell
25,679
-5,465
-18% -$272K 0.06% 276
2023
Q1
$1.31M Buy
+31,144
New +$1.34M 0.08% 225
2020
Q3
Sell
-11,507
Closed -$478K 1005
2020
Q2
$478K Buy
11,507
+1,766
+18% +$64.1K 0.03% 412
2020
Q1
$280K Sell
9,741
-3,547
-27% -$205K 0.02% 516
2019
Q4
$959K Buy
13,288
+1,401
+12% +$172K 0.04% 360
2019
Q3
$1.67M Sell
11,887
-713
-6% -$119K 0.08% 226
2019
Q2
$2.31M Sell
12,600
-1,393
-10% -$238K 0.11% 171
2019
Q1
$2.23M Buy
13,993
+1,127
+9% +$163K 0.11% 176
2018
Q4
$1.23M Sell
12,866
-3,101
-19% -$355K 0.08% 244
2018
Q3
$2.25M Buy
+15,967
New +$2.46M 0.09% 201

Other funds holding SAGE